The p53 tumor suppressor is the most commonly mutated gene In human cancer.
The p53 protein is stabilized in response to different checkpoints activat
ed by DNA damage, hypoxia, viral infection, or oncogene activation resultin
g in diverse biological effects, such as cell cycle arrest, apoptosis, sene
scence, differentiation and antiangiogenesis. The stable p53 protein is act
ivated by phosphorylation, dephosphorylation and acetylation yielding a pot
ent sequence-specific DNA-binding transcription factor. The wide range of p
53's biological effects can in part be explained by its activation of expre
ssion of a number of target genes including p21 (WAF1), GADD45, 14-3-3 sigm
a, bar, BTG2, PIG3, IGF-BP3 and others. p53 can induce or potentiate apopto
sis through several mechanisms, both by regulating the expression of genes
which can participate in the apoptotic response and through transcriptional
ly independent means. There appears to be cell type variability in both the
response to p53 expression and in the requirement for p53 transcriptional
transactivation for the induction of apoptosis.